The metastatic tumor harbored a PHOX2B deletion and a missense mutation of NRAS (p.Gln61Lys), whereas an ALK mutation (p.Phe1174Leu) was detected only in the primary tumor (Figure 5D). The gene discussed is NRAS; the disease is metastatic neoplasm.